CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Universidade de São Paulo (USP). Faculdade de Medicina de Ribeirão Preto (FMRP) (Institutional affiliation from the last research proposal) Birthplace: Brazil
I graduated in Physiotherapy (1992) and in Physical Education (1987) from the State University of Londrina. I attended a master's degree (1988) and doctorate (2002) in Sciences (Human Physiology) at the Ribeirão Preto Medical School, University of São Paulo/USP, and post-doc at the German Aerospace Institute, in the city of Cologne (2023). I was a professor at the State University of Londrina (UEL) in the Department of Physiological Sciences (1993-2005). I am currently an associate professor at the University of São Paulo/USP (since 2005). I am a teaching advisor (master's and doctorate) for the postgraduate program in Rehabilitation and Functional Performance (Physiotherapy) at the Ribeirão Preto Medical School/USP. I am a reviewer for several journals, including; Experimental Gerontology, Journal Applied Physiology, International Journal Cardiology, Autonomic Neuroscience, PLOS ONE, Annals of the Brazilian Academy of Sciences, Peptides, Revista Brasileira de Fisioterapia (1413-3555) and Frontiers in Physiology (I am also an area editor). I have experience in the area of Human Physiology, Cardiovascular Physiotherapy with an emphasis on Exercise Physiology, working mainly on the following topics: metabolic, cardiovascular and autonomic adaptations to physical exercise in healthy individuals and those with chronic-degenerative diseases (arterial hypertension, ovarian failure (menopause) , obesity, diabetes and metabolic syndrome). (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Introduction: The assessment of physical fitness through cardiorespiratory functional testing, using ergometers and metabolic analysers, represents a "gold standard" protocol to accurately quantify an individual's ability to use oxygen to produce energy in the face of increasing imposed resistance. The results of this exam are valuable in the diagnosis of diseases (cardiovascular, respira…
The expressive reduction in ovarian hormones that results from menopause increases the risk of developing cardiovascular disease, affecting cardiac and vascular morphology and functionality. However, some women already have cardiovascular disease even before menopause, such as systemic arterial hypertension (SAH). In this case, ovarian failure in these women can trigger even more signific…
We will investigate women in reproductive age and after physiological menopause the effects on hemodynamics, cardiac morphofunctionality, cardiovascular autonomic control, inflammatory markers, and oxidative stress due drug (Enalapril Maleate and Losartan) treatment with different action mechanisms on renin-angiotensin aldosterone system (RAAS). We will also investigate whether the associ…
(Only some records are available in English at this moment)
Introduction: Systemic arterial hypertension (SAH) is a highly prevalent disease in the adult population. Functional cardiac impairments are frequent, and if not contained, they can result in heart failure and favoring a poor prognosis. The search for more efficient pharmacological therapy has been constant. In this regard, monotherapy with AT1 receptor blockers, such as valsartan, as wel…
Introduction: We know little about the ability of hormone replacement therapy (HRT) to prevent or mitigate cardiovascular autonomic imbalances and adverse adaptations in cardiac morphology and functionality, inflammatory and oxidative stress profiles after premature ovarian failure (POF), and even less about the severity of these imbalances when associated with systemic arterial hypertens…
Molecular and cellular damage throughout life can lead to the development of pathological conditions. However, premenopausal women exhibit a lower incidence of cardiovascular diseases (CVDs) when compared to men of the same age. This lower predisposition to developing cardiovascular disorders is often attributed to the influence of ovarian hormones, particularly estrogens. After menopause…
(Only some records are available in English at this moment)
Introduction: Systemic arterial hypertension (SAH) is accompanied by a reduction in the cardiac contractile capacity and alterations in the reactivity of the coronary bed. However, in women of reproductive age, this condition may be less severe due to the cardiovascular protection exerted by ovarian hormones. In this context, physiological ovarian failure (menopause) would represent a wat…
Introduction: Systemic arterial hypertension (SAH) is accompanied by pathological left ventricular hypertrophy and alterations in cardiac functionality. However, in women of reproductive age, this condition may be less severe due to the cardiovascular protection exerted by ovarian hormones. In this context, physiological ovarian failure (menopause) would represent a watershed in this prot…
Introduction: Heart rate variability (HRV) is determined by physiological processes with different frequencies of occurrence. Among them, the sympathetic and parasympathetic autonomic components stand out. However, the heart also has intrinsic heart rate variability (iHRV) that can influence HRV and autonomic modulation on the heart. In this case, we suspect that cardiovascular diseases, …
(Only some records are available in English at this moment)
Introduction: Cardiovascular disease, primarily driven by endothelial dysfunction due to dyslipidemia, remains the leading cause of mortality globally. Endothelial inwardly-rectifying potassium (Kir2.1) channels play a crucial role in flow-induced vasodilation (FID) and nitric oxide (NO) production, both vital for vascular health. Research indicates that cholesterol enrichment suppresses …
The prevalence of hypertension among African-Americans is the highest in the world and it is increasing. Conversely, effective therapies, control and awareness of hypertension in African-Americans (AA) have declined over the last decade. This putsAA at a 180% higher risk of stroke, 400% higher risk of end stage renal disease and 150% higher rate of death attributable to heart disease. The…
The multiple systemic atrophy (MSA) is a rare disease, with rapid and fatal evolution, affecting the central nervous system in different ways. It is characterized by being a ±-synucleinopathy with particularities of parkinsonism or cerebellar and pyramidal dysfunction, occurring in different combinations. However, one of the main symptoms is autonomic disfunction which is responsible for …
| 1 / 1 | Ongoing grants |
| 12 / 11 | Completed research grants |
| 8 / 8 | Ongoing scholarships in Brazil |
| 21 / 21 | Completed scholarships in Brazil |
| 1 / 1 | Ongoing scholarships abroad |
| 2 / 2 | Completed scholarships abroad |
| 45 / 44 | All research grants and scholarships |
| Associated processes | |